These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 30195192)

  • 1. The changing landscape of naloxone availability in the United States, 2011 - 2017.
    Freeman PR; Hankosky ER; Lofwall MR; Talbert JC
    Drug Alcohol Depend; 2018 Oct; 191():361-364. PubMed ID: 30195192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States.
    Sohn M; Talbert JC; Huang Z; Lofwall MR; Freeman PR
    JAMA Netw Open; 2019 Jun; 2(6):e196215. PubMed ID: 31225895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States.
    Lambdin BH; Davis CS; Wheeler E; Tueller S; Kral AH
    Drug Alcohol Depend; 2018 Jul; 188():370-376. PubMed ID: 29776688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Legal changes to increase access to naloxone for opioid overdose reversal in the United States.
    Davis CS; Carr D
    Drug Alcohol Depend; 2015 Dec; 157():112-20. PubMed ID: 26507172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Legal requirements and recommendations to prescribe naloxone.
    Haffajee RL; Cherney S; Smart R
    Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do naloxone access laws increase outpatient naloxone prescriptions? Evidence from Medicaid.
    Gertner AK; Domino ME; Davis CS
    Drug Alcohol Depend; 2018 Sep; 190():37-41. PubMed ID: 29966851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent Naloxone Dispensing Among Individuals with High-Risk Opioid Prescriptions, USA, 2015-2019.
    Guy GP; Strahan AE; Haegerich T; Losby JL; Ragan K; Evans ME; Jones CM
    J Gen Intern Med; 2021 Oct; 36(10):3254-3256. PubMed ID: 33751410
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between state Medicaid expansion status and naloxone prescription dispensing.
    Sohn M; Talbert JC; Delcher C; Hankosky ER; Lofwall MR; Freeman PR
    Health Serv Res; 2020 Apr; 55(2):239-248. PubMed ID: 32030751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State laws that authorize pharmacists to prescribe naloxone are associated with increased naloxone dispensing in retail pharmacies.
    Xu J; Mukherjee S
    Drug Alcohol Depend; 2021 Oct; 227():109012. PubMed ID: 34482035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vital Signs: Pharmacy-Based Naloxone Dispensing - United States, 2012-2018.
    Guy GP; Haegerich TM; Evans ME; Losby JL; Young R; Jones CM
    MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(31):679-686. PubMed ID: 31393863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.
    Green TC; Dauria EF; Bratberg J; Davis CS; Walley AY
    Harm Reduct J; 2015 Aug; 12():25. PubMed ID: 26245865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study.
    Irvine MA; Oller D; Boggis J; Bishop B; Coombs D; Wheeler E; Doe-Simkins M; Walley AY; Marshall BDL; Bratberg J; Green TC
    Lancet Public Health; 2022 Mar; 7(3):e210-e218. PubMed ID: 35151372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in Naloxone Prescriptions Dispensed in US Retail Pharmacies Since 2013.
    Jones CM; Lurie PG; Compton WM
    Am J Public Health; 2016 Apr; 106(4):689-90. PubMed ID: 26890174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State legal innovations to encourage naloxone dispensing.
    Davis C; Carr D
    J Am Pharm Assoc (2003); 2017; 57(2S):S180-S184. PubMed ID: 28073688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Opioid Crisis and the Physician's Role in Contributing to its Resolution: Step One--Prevention of Overdoses.
    Wolfe S; Bouffard DL; Modesto-Lowe V
    Conn Med; 2016; 80(6):325-34. PubMed ID: 27509638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014.
    Wheeler E; Jones TS; Gilbert MK; Davidson PJ;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):631-5. PubMed ID: 26086633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone dispensing among the commercially insured population in the United States from 2015 to 2018.
    Dunphy C; Zhang K; Guy GP; Jones CM
    Prev Med; 2021 Dec; 153():106820. PubMed ID: 34599923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combative Treatment for Carfentanil Epidemic.
    Konapur R; Searls N; Babcock CCK; Blough E; Patel I
    J Addict Nurs; 2019; 30(1):2-3. PubMed ID: 30829994
    [No Abstract]   [Full Text] [Related]  

  • 19. Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose.
    Donovan E; Case P; Bratberg JP; Baird J; Burstein D; Walley AY; Green TC
    J Urban Health; 2019 Jun; 96(3):367-378. PubMed ID: 30747371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.
    Bachyrycz A; Shrestha S; Bleske BE; Tinker D; Bakhireva LN
    Subst Abus; 2017; 38(1):55-60. PubMed ID: 27164192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.